바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.73 No.2
Citation Share

The Efficacy of Immediate Diet for Reducing Local Adverse Events of Inhaled Corticosteroid: A Pilot Study

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2012, v.73 no.2, pp.93-99
Myoung Kyu Lee (Yonsei University Wonju College of Medicine)




Chong Whan Kim (Yonsei University Wonju College of Medicine)
Ji-Ho Lee (Yonsei University Wonju College of Medicine)
Saehyun Jung (Yonsei University Wonju College of Medicine)
Ye-Ryung Jung (Yonsei University Wonju College of Medicine)
Hyun Sik Kim (Yonsei University Wonju College of Medicine)
Tae-Sun Yu (Yonsei University Wonju College of Medicine)
Myoung, K. L. , Chong, W. K. , Ji-Ho, L. , Saehyun, J. , Ye-Ryung, J. , Hyun, S. K. , & Tae-Sun, Y. (2012). The Efficacy of Immediate Diet for Reducing Local Adverse Events of Inhaled Corticosteroid: A Pilot Study. Tuberculosis & Respiratory Diseases, 73(2), 93-99.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Local adverse events associated with inhaled corticosteroid use, including dysphonia, pharyngitis and oral candidiasis, can affect adherence for treatment. 'Mouth rinsing method' has been used for reducing local adverse events, but it cannot ensure complete prevention. The goal of this pilot study was to identify whether the 'immediate diet method' can reduce local adverse events in a limited number of patients. Methods: The study was conducted in a total of 98 patients, who had been prescribed a medium-dose fluticasone propionate for the first time, from January to October in 2010. One training nurse had performed the education on how to use the inhaler, including the mouth rinsing method. And with follow-ups at one month intervals, any patient who experienced such adverse events were educated on the immediate diet method, having a meal within 5 minutes after using an inhaler and they were checked on any incurrence of adverse events with one month intervals for 2 months. Results: The mean age of patients was 65.9 years old. The local adverse events had incurred from 18.4% of the study subjects. When performed the follow-up observation in 18 patients with local adverse events after education on the immediate diet method, 14 patients (77.8%) had shown symptomatic improvements. Three of 4 patients did not show any improvement, in spite of implementing the immediate diet method. The other 1 patient did not practice the immediate diet method properly. Conclusion: The immediate diet method may be useful in reducing the local adverse events, caused by the use of inhaled corticosteroid.

keywords
Steroids, Drug Toxicity, Candidiasis, Oral, Pharyngitis, Dysphonia

Reference

1.

1. Szefler SJ. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991;88:147-65.

2.

2. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995;98:196-208.

3.

3. Maxwell DL. Adverse effects of inhaled corticosteroids. Biomed Pharmacother 1990;44:421-7.

4.

4. Roland NJ, Bhalla RK, Earis J. The local side effects of inhaled corticosteroids: current understanding and review of the literature. Chest 2004;126:213-9.

5.

5. Toogood JH, Jennings B, Greenway RW, Chuang L. Candidiasis and dysphonia complicating beclomethasone treatment of asthma. J Allergy Clin Immunol 1980;65:145-53.

6.

6. Selroos O, Halme M. Effect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler. Thorax 1991;46:891-4.

7.

7. Yokoyama H, Yamada Y, Yamamura Y, Nakamura H, Iga T. Effect of mouth wash on the removing fluticasone propionate delivered by dry powder inhaler in mouth. Yakugaku Zasshi 2001;121:233-7.

8.

8. Dubus JC, Marguet C, Deschildre A, Mely L, Le Roux P, Brouard J, et al. Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device. Allergy 2001;56:944-8.

9.

9. Toogood JH. Complications of topical steroid therapy for asthma. Am Rev Respir Dis 1990;141(2 Pt 2):S89-96.

10.

10. Pauwels RA, Hargreave FE, Camus P, Bukoski M, Ståhl E. A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients. Chest 1996;110:53-7.

11.

11. Rachelefsky GS, Liao Y, Faruqi R. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from a meta-analysis. Ann Allergy Asthma Immunol 2007;98:225-38.

12.

12. Richter K, Kanniess F, Biberger C, Nave R, Magnussen H. Comparison of the oropharyngeal deposition of inhaled ciclesonide and fluticasone propionate in patients with asthma. J Clin Pharmacol 2005;45:146-52.

13.

13. Knight L, Fletcher J. Growth of Candida albicans in saliva: stimulation by glucose associated with antibiotics, corticosteroids, and diabetes mellitus. J Infect Dis 1971;123:371-7.

14.

14. Williams AJ, Baghat MS, Stableforth DE, Cayton RM, Shenoi PM, Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax 1983;38:813-21.

15.

15. Buhl R. Local oropharyngeal side effects of inhaled corticosteroids in patients with asthma. Allergy 2006;61: 518-26.

16.

16. Hood S, Evans J, Bond J, Wilkins E, Denning D. The treatment of oropharyngeal candidiasis in HIV-infected patients with oral amphotericin B suspension. AIDS Patient Care STDS 1998;12:625-7.

17.

17. Brand P, Hederer B, Austen G, Dewberry H, Meyer T. Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique. Int J Chron Obstruct Pulmon Dis 2008;3:763-70.

18.

18. Lee JK, Yang YH. Evaluation of an education program for patients with asthma who use inhalers. J Korean Acad Nurs 2010;40:202-12.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy